Dentons capital and venture growth practice draws on extensive experience executing transactions across a broad spectrum of financings, including angel and seed rounds, Series A and B, follow-on rounds, corporate venture investments, bridge and mezzanine financings. The team is particularly recognised for assisting VC funds investing in multiple jurisdictions. Practice head Olivia Guéguen leads cross-border teams in structuring transactions and supports clients with investment solutions.
\n
\n
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team distinguished itself through its exceptional responsiveness and its keen understanding of the issues from the very first discussions. It combines a pragmatic and efficient approach with a genuine capacity for adaptation.'
Key clients
- Volta Group
- Bpifrance Large Venture
- Sparta
- Sofinnova
- The Institute for Follicular Lymphoma Innovation
- Vsquared Ventures
- ImCheck
Work highlights
Advised the Volta Group on two separate financing transactions supporting its expansion and development of renewable energy infrastructure.
Advised Bpifrance Large Venture on its renewed investment in Aqemia, a cutting-edge Paris-based biotech company. This was part of a $38m Series C funding round led by Cathay Innovation, with participation from Wendel Growth, Eurazeo, Elaia and other existing backers.
Advised Sparta Capital and Sofinnova Partners, shareholders of GFBiochemicals, on GFBiochemicals’ €10 m fundraising round.
Practice head
Olivia Guéguen
Other key lawyers
Guillaume Kessler; Pascal Chadenet; Laura Godard; Pierre-Marie Gallo; Caroline Pucel